After hours
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Sale
Calculated transaction value
$445.07K

Rothblatt Martine A Chairperson & CEO

Transaction date Jun 18, 2026
Public filing date Jun 22, 2026
Filing lag Filed 4 days later

UTHR daily price context

Close on/before transaction
$536.59 Jun 18, 2026
First close after public filing
$544.33 Jun 23, 2026
30-day return after filing
-3.17% Through Jul 22, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
828 shares @ $537.52
SEC ownership
Direct
Transaction code
S
Form
4
Filing identifier
0001106578-26-000082
Filing cohort

Transactions in this filing

Showing 15 of 15
Trades
15
Issuers
1
Estimated value
$6.52M
Buys / sales
0 / 13
Transactions reported in the same official filing
Issuer Transaction Traded Value
United Therapeutics Corp UTHR Exercise Jun 18, 2026 $1.39M
United Therapeutics Corp UTHR Sale Jun 18, 2026 $256.22K
United Therapeutics Corp UTHR Sale Jun 18, 2026 $42.8K
United Therapeutics Corp UTHR Sale Jun 18, 2026 $131.47K
United Therapeutics Corp UTHR Current Sale Jun 18, 2026 $445.07K
United Therapeutics Corp UTHR Sale Jun 18, 2026 $753.49K
United Therapeutics Corp UTHR Sale Jun 18, 2026 $1.51M
United Therapeutics Corp UTHR Sale Jun 18, 2026 $1.09M
United Therapeutics Corp UTHR Sale Jun 18, 2026 $331.94K
United Therapeutics Corp UTHR Sale Jun 18, 2026 $21.76K
United Therapeutics Corp UTHR Sale Jun 18, 2026 $21.81K
United Therapeutics Corp UTHR Sale Jun 18, 2026 $175.2K
United Therapeutics Corp UTHR Sale Jun 18, 2026 $263.45K
United Therapeutics Corp UTHR Sale Jun 18, 2026 $88.44K
United Therapeutics Corp UTHR Exercise Jun 18, 2026 $0